Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study (Q33819964)

29 July 2017

title

Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study (English)

1 reference

29 July 2017

1 reference

Gholson J Lyon

1

1 reference

29 July 2017

Stephanie Samar

2

1 reference

29 July 2017

Rahil Jummani

3

1 reference

29 July 2017

Scott Hirsch

4

1 reference

29 July 2017

Arie Spirgel

5

1 reference

29 July 2017

Rachel Goldman

6

1 reference

29 July 2017

Barbara J Coffey

7

1 reference

29 July 2017

publication date

1 December 2009

1 reference

Journal of Child and Adolescent Psychopharmacology

29 July 2017

published in

1 reference

29 July 2017

volume

19

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

623-633

1 reference

Pimozide for tics in Tourette's syndrome

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

Informativeness of structured diagnostic interviews in the identification of Tourette's disorder in referred youth

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

Treatment of Tourette's syndrome with haloperidol, review of 34 cases

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

Aripiprazole in the pharmacotherapy of Gilles de la Tourette syndrome in adult patients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

Aripiprazole in a case presenting with tourette syndrome and obsessive-compulsive disorder

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

Changes in weight and weight-related quality of life in a multicentre, randomized trial of aripiprazole versus standard of care

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

Aripiprazole for the treatment of Tourette's syndrome

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

Aripiprazole: a treatment for severe coprolalia in "refractory" Gilles de la Tourette syndrome

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

Case series on the use of aripiprazole for Tourette syndrome

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

Aripiprazole in a patient vulnerable to side effects

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

Aripiprazole and Tourette syndrome

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

Treatment of tics in tourette syndrome with aripiprazole

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861961

Acute dystonia with low-dosage aripiprazole in Tourette's disorder

29 October 2018

1 reference

12 December 2020

Aripiprazole in patients with Tourette syndrome

1 reference

12 December 2020

Aripiprazole in childhood and adolescence for Tourette syndrome

1 reference

12 December 2020

A pilot study of aripiprazole in children and adolescents with Tourette's disorder

1 reference

12 December 2020

A case series of patients with Tourette's syndrome in the United Kingdom treated with aripiprazole

1 reference

12 December 2020

Aripiprazole is effective in the treatment of Tourette's disorder

1 reference

12 December 2020

Identifiers

DOI

10.1089/CAP.2009.0035

1 reference

release_kc2sb3svjnbvlbnmkb3n7bwwdi

29 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kc2sb3svjnbvlbnmkb3n7bwwdi

24 November 2022

mapped directly with Wikidata item

PMC publication ID

2861961

1 reference

29 July 2017

1 reference